Skip to content

The Study of Efficacy and Mechanism in Fecal Microbiota Transplantation in the Treatment of Ulcerative Colitis

Status
UNKNOWN
Phases
Phase 2Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02435160
Enrollment
20
Registered
2015-05-06
Start date
2015-05-31
Completion date
Unknown
Last updated
2015-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fecal Microbiota Transplantation, Ulcerative Colitis

Brief summary

The aim of our study is to investigate the efficacy and mechanism in fecal microbiota transplantation in the treatment of ulcerative colitis. About 20 Ulcerative Colitis (UC) patients will be recruited into our trial for Fecal Microbiota Transplantation (FMT) treatment,the safety and efficacy of FMT will be observed.

Interventions

BIOLOGICALFecal Microbiota Transplantation

Sponsors

Jun Liu
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
MALE
Age
25 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* mild to moderate UC patients * male * volunteered to our FMT trial

Exclusion criteria

* severe UC * Hb \< 6g/dL

Design outcomes

Primary

MeasureTime frame
Change of mayo criteria in UC patients after FMT.one year
Number of patients with adverse events after FMT.one year

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 11, 2026